262 filings
Page 5 of 14
8-K
evnwgk 9cwb2bk0w
6 Jan 20
Entry into a Material Definitive Agreement
4:26pm
8-K
l5zwoqle9y
11 Dec 19
Other Events
7:52am
8-K
cv9yh43 glsbb7jh
25 Nov 19
Entry into a Material Definitive Agreement
5:08pm
8-K
ambdczyr
12 Nov 19
Entry into a Material Definitive Agreement
3:08pm
8-K/A
1wqp7y9lio48u sg
5 Nov 19
Entry into a Material Definitive Agreement
3:35pm
D
8c1 brzhw2f
5 Nov 19
$1M in debt / options / securities to be acquired, sold $332.3K, 1 investor
1:50pm
8-K
kv07 l13p
28 Oct 19
Entry into a Material Definitive Agreement
9:13am
8-K
arro0bcviou68iyk4 gn
13 Sep 19
Bioxytran Inc. Appoints Two Investment Bankers from Westbury Group to Its Advisory Board
2:56pm
8-K
judsg 0sm
1 Aug 19
Bioxytran Inc. Bolsters Advisory Board with Addition of Veteran Financial Advisor Jonathan Barkman
3:32pm
8-K
ski4p3nb2hxo867n3ppj
12 Jun 19
Bioxytran, Inc. Announces Public Company Executive Steve Aust to Join Advisory Board
9:02am
8-K
9dax1qhys6hez3mr0
29 May 19
Bioxytran Inc. Announces Availability of Updated Investor Presentation
1:29pm
8-K
5n5vdrbw
6 May 19
Bioxytran Inc. Announces Appointment of Ex Bristol-Myers Squibb Executive to Scientific Advisory Board
9:39am
8-K
ubqwedssfwj3zzhbia4
26 Apr 19
Entry into a Material Definitive Agreement
5:16pm
8-K
me9yi5f
5 Apr 19
Bioxytran Licensing FDA Approved Technology from MDX Lifesciences for use in Pipeline Drug Development
4:25pm
8-K
vv323pqc dn
1 Mar 19
Entry into a Material Definitive Agreement
10:08am
EFFECT
l6ondkudoaoqd w39pp0
14 Feb 19
Notice of effectiveness
12:00am